Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
sars decrease » mass decrease (Expand search), skins decrease (Expand search), roads decrease (Expand search)
decrease hiv » decrease in (Expand search), decrease their (Expand search), decreased high (Expand search)
hiv decrease » via decrease (Expand search), hiv increase (Expand search), will decrease (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
sars decrease » mass decrease (Expand search), skins decrease (Expand search), roads decrease (Expand search)
decrease hiv » decrease in (Expand search), decrease their (Expand search), decreased high (Expand search)
hiv decrease » via decrease (Expand search), hiv increase (Expand search), will decrease (Expand search)
1
“... effects.Objective: To investigate possible adverse effects after vaccination against COVID-19 in adults...”
Access document
Access document
Article
2
3
4
“.... The aim of this study was to estimate the seroprevalence of antibodies against SARS-CoV...”
Access document
Access document
Article
5
6
7
8
9
10
Cross-reaction and co-infection with DENV and SARS-CoV-2 in Brazil: a case series: Reação cruzada...
Subjects:
“...SARS-CoV-2...”Access document
Article
11
12
“...%). Conclusions With regard to estimates of the VE against SARS-CoV-2 confirmed by laboratory tests, we noted...”
Access document
Access document
Master thesis
13
14
15
16
17
“..., we did not observe a quantitative correlation between IFN-γ and IgG levels against SARS-CoV-2. Using...”
Access document
Access document
Article
18
19
20